Copertina

Cytarabine‐Related Neurotoxicity in an Infant With Acute Lymphoblastic Leukemia

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Ashley C. Holland, Margit K. Mikkelsen, Soniya Pinto, Noah D. Sabin, Lu Wang, Bradley Muller, Raja B. Khan, Hiroto Inaba
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pediatric Blood & Cancer
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Reduced‐Intensity Chemotherapy With Immunotherapy for Children With Down Syndrome and B‐Cell Acute Lymphoblastic Leukemia
di: Ashley C. Holland, et al.
Pubblicazione: (2025)

Blinatumomab‐Associated Psychosis in an Adolescent With B‐Cell Acute Lymphoblastic Leukemia
di: Eesha A. Zaheer, et al.
Pubblicazione: (2026)

Late Onset Blinatumomab‐Related Neurotoxicity in a Child With B‐Cell Acute Lymphoblastic Leukemia
di: Krunal Shah, et al.
Pubblicazione: (2025)

BCG Infection Following Therapy of Infant Acute Lymphoblastic Leukemia
di: Mikhail Lemeshev, et al.
Pubblicazione: (2026)

Recurrent Immune‐Effector Cell‐Associated Neurotoxicity Syndrome With Atypical Manifestations after Tisagenlecleucel
di: Devin Murphy, et al.
Pubblicazione: (2025)

A Retrospective Study to Identify Demographic and Clinical Risk Factors for the Development of Methotrexate‐Associated Neurotoxicity in Children and Young Adults With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
di: Cassandra Grello, et al.
Pubblicazione: (2025)

Pediatric Hematology/Oncology Fellowship Match Trends in the United States: Analysis From 2008 to 2025
di: Saman K. Hashmi, et al.
Pubblicazione: (2025)

Management of Philadelphia Chromosome‐Positive B‐Lymphoblastic Leukemia Diagnosed in an Infant
di: Jessica A. O. Zimmerman, et al.
Pubblicazione: (2025)

Monosomy 10 Mosaicism as an Incidental Finding in Acute Lymphoblastic Leukemia
di: Dany Assaf Curi, et al.
Pubblicazione: (2025)

Treatment of a pediatric patient with concurrent neuroblastoma and acute lymphoblastic leukemia
di: Megan M. Lilley, et al.
Pubblicazione: (2024)

Serological Benefit of SARS‐CoV‐2 Vaccination Relative to Infection in Children With Acute Lymphoblastic Leukemia
di: Janna R. Shapiro, et al.
Pubblicazione: (2026)

Visceral Fat and Body Fat as Risk Factors for Methotrexate Toxicity in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
di: Alda Daniela García‐Guzmán, et al.
Pubblicazione: (2025)

Transient Abnormal Myelopoiesis in a Non‐Down Syndrome Infant With Subsequent Evolution to Acute Myeloid Leukemia
di: Brock Bradley, et al.
Pubblicazione: (2026)

Pediatric B‐Cell Acute Lymphoblastic Leukemia With FUS::FLI1 Fusion in an Infant With Measurable Residual Disease: Sustained Molecular Remission Achieved With Blinatumomab
di: Qiang Yao, et al.
Pubblicazione: (2025)

Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia
di: Laura Almási, et al.
Pubblicazione: (2026)

Disseminated Infection Following the Administration of the Varicella Vaccine in a Child with Acute Lymphoblastic Leukemia
di: Ryo Hanaki, et al.
Pubblicazione: (2025)

Blinatumomab Utilization in Pediatric B‐Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West
di: Angela Parra del Riego, et al.
Pubblicazione: (2026)

Use of Oral Metformin Therapy for Therapy‐Induced Hyperglycemia in Pediatric Patients With Acute Lymphoblastic Leukemia
di: Ankita Chakraborty, et al.
Pubblicazione: (2026)

Venetoclax Plus Daratumumab Bridging Allo‐HSCT in Early T‐Cell Precursor Acute Lymphoblastic Leukemia
di: Fanqiao Meng, et al.
Pubblicazione: (2025)

Attitudes Toward COVID‐19 Vaccination Among Pediatric Acute Lymphoblastic Leukemia Patients and Their Caregivers
di: Janna R. Shapiro, et al.
Pubblicazione: (2025)

Characterizing Parental Concerns About Lasting Impacts of Treatment in Children With B‐Acute Lymphoblastic Leukemia
di: Kellee N. Parker, et al.
Pubblicazione: (2026)

Caregiving for Children With Acute Lymphoblastic Leukemia Receiving Home‐Based Blinatumomab: Caregiver Experiences and Recommendations
di: Sue Zupanec, et al.
Pubblicazione: (2025)

Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post‐Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation
di: Irtiza N. Sheikh, et al.
Pubblicazione: (2024)

Impact of Invasive Fungal Diseases on Treatment Outcomes in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Insights From a Single‐Center Study
di: Amrutha Narayana Murthy, et al.
Pubblicazione: (2025)

A Rare Case of Infant B‐ALL With SIN3A::NUTM1 Fusion: Durable Molecular Remission Achieved With Standard Acute Lymphoblastic Leukemia Chemotherapy
di: Dong Peng, et al.
Pubblicazione: (2026)

Pediatric Acute B‐Lymphoblastic Leukemia Presenting as Hypereosinophilia With Lung Involvement and Elevated Immunoglobulin E Levels
di: Aida Zeckanovic, et al.
Pubblicazione: (2024)

Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
di: Andrew E. Place, et al.
Pubblicazione: (2025)

Quality of Life Priorities of Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC Studies, and a Comparison of Instruments
di: Jammbe Musoro, et al.
Pubblicazione: (2024)

Prolonged Hypogammaglobulinemia in a Child With Down Syndrome After Treatment of Acute Lymphoblastic Leukemia With Immunochemotherapy Including Blinatumomab
di: Reena Pabari, et al.
Pubblicazione: (2025)

First‐Line Postremission Blinatumomab as Successful Toxicity‐Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia
di: Nicolò Peccatori, et al.
Pubblicazione: (2025)

Central Adiposity and Visceral Fat in Long‐Term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence: Exploration of an Underappreciated Risk
di: Louise Guolla, et al.
Pubblicazione: (2025)

Successful Caribbean Cooperation in Childhood Cancer Care: The Martinique—St. Lucia–Dominica Experience in the Management of Acute Lymphoblastic Leukemia
di: Julie Mascle, et al.
Pubblicazione: (2025)

Results of a Randomized Augmented Intensification Phase in Acute Lymphoblastic Leukemia in Children in Argentina: GATLA 2010 ALL IC Trial
di: Maria C. Riccheri, et al.
Pubblicazione: (2025)

Bridging the Gap in Pediatric Relapsed Acute Lymphoblastic Leukemia Treatment: Insights and Outcomes From the ALL‐IC REL 2016 Guidelines
di: Marko Kavcic, et al.
Pubblicazione: (2025)

Changes in Body Composition in Children and Young People Undergoing Treatment for Acute Lymphoblastic Leukemia: A Systematic Review and Meta‐Analysis
di: Lina A. Zahed, et al.
Pubblicazione: (2026)

Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial
di: Nirali N. Shah, et al.
Pubblicazione: (2025)

Risk of Metabolic Syndrome and Glucose Homeostasis Among Childhood and Young Adult Acute Lymphoblastic Leukemia Survivors: Part of the ALL‐STAR Study
di: Mette Tiedemann Skipper, et al.
Pubblicazione: (2025)

Successful Medical Management of Gastrointestinal Invasive Mucormycosis with Associated Bowel Perforation in an Adolescent Patient with pre‐B Cell Acute Lymphoblastic Leukemia
di: Heather Valdin, et al.
Pubblicazione: (2025)

Association Between Maternal Infection During Pregnancy and the Risk of Childhood Acute Lymphoblastic Leukemia in Offspring: A Systematic Review and Meta‐Analysis
di: Xi Chen, et al.
Pubblicazione: (2026)

Neurologic Morbidity in Survivors of Childhood Hodgkin Lymphoma Treated With Radiation
di: Raja B. Khan, et al.
Pubblicazione: (2026)